Literature DB >> 31388923

LncRNA terminal differentiation-induced ncRNA (TINCR) sponges miR-302 to upregulate cyclin D1 in cervical squamous cell carcinoma (CSCC).

Anli Hou1, Yali Zhang2, Yi Zheng3, Yujuan Fan4, Huilan Liu4, Xiuying Zhou4.   

Abstract

This study aimed to investigate the role of lncRNA terminal differentiation-induced ncRNA (TINCR) in cervical squamous cell carcinoma (CSCC). By informatics analysis, we found that miR-302 may bind TINCR. Expression analysis showed that miR-302 was downregulated, while TINCR was upregulated in CSCC. Correlation analysis showed that they were not significantly correlated. In CSCC cells, miR-302 and TINCR failed to affect the expression of each other. However, miR-302 overexpression led to downregulated and TINCR overexpression led to upregulated cyclin D1 expression in CSCC cells. Interestingly, overexpression of cyclin D1 led to upregulated miR-302 and TINCR. Cell proliferation analysis showed that TINCR and cyclin D1 overexpression led to increased, while miR-302 overexpression led to decreased rate of cell proliferation. Moreover, miR-302 overexpression reduced the effects of TINCR overexpression. Therefore, TINCR sponges miR-302 to upregulate cyclin D1 in CSCC, thereby promoting cell proliferation.

Entities:  

Keywords:  Cervical squamous cell carcinoma; Cyclin D1; LncRNA TINCR; MiR-302; Proliferation

Mesh:

Substances:

Year:  2019        PMID: 31388923     DOI: 10.1007/s13577-019-00268-y

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  18 in total

1.  Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells.

Authors:  Deborah A Greer Card; Pratibha B Hebbar; Leping Li; Kevin W Trotter; Yoshihiro Komatsu; Yuji Mishina; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

Review 2.  Identification and consequences of miRNA-target interactions--beyond repression of gene expression.

Authors:  Jean Hausser; Mihaela Zavolan
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

Review 3.  MicroRNA and cancer--a brief overview.

Authors:  Mario Acunzo; Giulia Romano; Dorothee Wernicke; Carlo M Croce
Journal:  Adv Biol Regul       Date:  2014-09-28

4.  CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes.

Authors:  Noel Faherty; Simon P Curran; Helen O'Donovan; Finian Martin; Catherine Godson; Derek P Brazil; John K Crean
Journal:  J Cell Sci       Date:  2012-09-12       Impact factor: 5.285

5.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 6.  Functional interactions among microRNAs and long noncoding RNAs.

Authors:  Je-Hyun Yoon; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Semin Cell Dev Biol       Date:  2014-06-02       Impact factor: 7.727

Review 7.  Alternative dosage schedules with HPV virus-like particle vaccines.

Authors:  Margaret A Stanley; Staci L Sudenga; Anna R Giuliano
Journal:  Expert Rev Vaccines       Date:  2014-07-07       Impact factor: 5.217

Review 8.  Global burden of human papillomavirus and related diseases.

Authors:  David Forman; Catherine de Martel; Charles J Lacey; Isabelle Soerjomataram; Joannie Lortet-Tieulent; Laia Bruni; Jerome Vignat; Jacques Ferlay; Freddie Bray; Martyn Plummer; Silvia Franceschi
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

Review 9.  Pathogenesis of human papillomavirus-associated mucosal disease.

Authors:  Ian J Groves; Nicholas Coleman
Journal:  J Pathol       Date:  2015-01-20       Impact factor: 7.996

10.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

Authors:  G M Clifford; J S Smith; M Plummer; N Muñoz; S Franceschi
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more
  5 in total

1.  CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway.

Authors:  Biyin Chen; Li Song; Xiuzhen Nie; Fangfeng Lin; Zongyang Yu; Wencui Kong; Xiaoyan Qi; Wenwu Wang
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

2.  Dysregulation of Transcription Factor Networks Unveils Different Pathways in Human Papillomavirus 16-Positive Squamous Cell Carcinoma and Adenocarcinoma of the Uterine Cervix.

Authors:  Saloe Bispo; Ticiana D J Farias; Patricia Savio de Araujo-Souza; Ricardo Cintra; Hellen Geremias Dos Santos; Natasha Andressa Nogueira Jorge; Mauro Antônio Alves Castro; Gabriel Wajnberg; Nicole de Miranda Scherer; Maria Luiza Nogueira Dias Genta; Jesus Paula Carvalho; Luisa Lina Villa; Laura Sichero; Fabio Passetti
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

3.  LncLocation: Efficient Subcellular Location Prediction of Long Non-Coding RNA-Based Multi-Source Heterogeneous Feature Fusion.

Authors:  Shiyao Feng; Yanchun Liang; Wei Du; Wei Lv; Ying Li
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

4.  Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer.

Authors:  Xiaojie Wang; Shuang Li; Huiyu Xiao; Xiaoqin Deng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).

Authors:  Chengwu Tang; Wenming Feng; Ying Bao; Huimin Du
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.